No buyers even at 0.001 for a reason. Chances of this one still be listed on ASX by 2027 is almost zeor...Hope yopur pathetic attempt of pumping this would work
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%